Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Middle East Journal of Digestive Diseases. 2016; 8 (1): 19-23
in English | IMEMR | ID: emr-177593

ABSTRACT

Background: In the Golestan Cohort Study that was launched to investigate the causes of esophageal cancer, a complete biospecimen bank was established for storage of collected blood, urine, hair, and nail samples. The objective of this study was to evaluate the feasibility of nail samples as a biomarker of selected trace elements status


Methods: Thirty toenail samples were selected randomly from the participants of Golestan Cohort Study [GCS]. The samples were cleaned and analyzed for selenium, mercury, chromium, iron, zinc, and scandium by instrumental neutron activation analysis at the University of Missouri Research Reactor Center. Pearson correlation coefficients were computed for selected trace elements concentration versus scandium concentration to assess terrestrial contamination


Results: The selenium, zinc, and mercury were not correlated with scandium, suggesting they were free from substantial contamination. The high correlations of scandium with iron and chromium suggest that the iron and chromium levels may be compromised by terrestrial contamination. The coefficients of variation for duplicate samples for selenium and zinc were 2.6% and 7.2%, respectively


Conclusion: The nail samples from Golestan Cohort Study appears to be useable as a biomarker of selenium, zinc, and mercury and could be considered for use in future studies


Subject(s)
Humans , Trace Elements , Cohort Studies , Biomarkers
2.
Middle East Journal of Digestive Diseases. 2014; 6 (4): 177-185
in English | IMEMR | ID: emr-148750

ABSTRACT

It is hypothesized that poor zinc nutritional status is associated with an increased risk of esophageal cancer [EC], but current evidence is contradictory. Since some factors may influence zinc absorption, its status may be better evaluated thorough biomarkers. The objectives of this study were to perform a systematic review on the association of zinc biomarkers with EC in observational studies and to evaluate the efficacy of zinc supplements in preventing EC in randomized trials. The MEDLINE database was searched in December 2013 for studies written in English with relevant keywords. Articles which met inclusion criteria were included in this study. Eleven observational studies that measured zinc biomarkers and eight randomized trials which evaluated supplements containing zinc, met our inclusion criteria. The majority of studies suggested that higher zinc status was inversely associated with EC risk. Most of the evidence for this hypothesis comes from case-control studies, which may introduce bias. Cohort studies are needed to establish whether poor zinc status is associated with increased risk for EC. Findings from trials are inconclusive as there is no data from single agent trials. However, the evidence is not still strong enough to conclude a protective role of zinc in EC


Subject(s)
Humans , Male , Female , Animals, Laboratory , Animals , Insecta , Esophageal Neoplasms , Biomarkers , Risk
3.
Archives of Iranian Medicine. 2013; 16 (1): 46-53
in English | IMEMR | ID: emr-130535

ABSTRACT

The Gastro-Esophageal Malignancies in Northern Iran [GEMINI] research project is an example of recent progress in health research in Iran. The original aim of this project was to identify etiologic factors and prevention measures for upper gastrointestinal cancers in Northern provinces of Iran, but its achievements have gone much beyond this initial goal. GEMINI consists of several projects including cancer registries, pilot studies, case-control studies, and the Golestan Cohort Study. GEMINI has been conducted through extensive collaborations between the Digestive Disease Research Center of Tehran University of Medical Sciences with other domestic and international health organizations. The achievements of GEMINI include producing new knowledge, introducing new research methods, developing and expanding health research and health care infrastructures, investing in human resources, and increasing the awareness and knowledge of policy makers and officials at all levels about the importance of chronic diseases in Iran's health priorities. The success of GEMINI reveals the feasibility of large-scale health research studies in developing countries and serves as a successful model not only for health research in Iran, but also for similar research studies in other developing nations


Subject(s)
Humans , Chronic Disease , Research , Research Design , Gastroenterology , Delivery of Health Care , Community Health Planning , Health Promotion
4.
Archives of Iranian Medicine. 2012; 15 (1): 18-21
in English | IMEMR | ID: emr-122404

ABSTRACT

Identifying people at higher risk of having squamous dysplasia, the precursor lesion for esophageal squamous cell carcinoma [ESCC], would allow targeted endoscopic screening. We used multivariate logistic regression models to predict ESCC and dysplasia as outcomes. The ESCC model was based on data from the Golestan Case-Control Study [total n = 871; cases = 300], and the dysplasia model was based on data from a cohort of subjects from a gastroenterology clinic in Northeast Iran [total n = 724; cases = 26]. In each of these analyses, we fit a model including all risk factors known in this region to be associated with ESCC. Individual risks were calculated using the linear combination of estimated regression coefficients and individual-specific values for covariates. We used cross-validation to determine the area under the curve [AUC] and to find the optimal cut points for each of the models. The model had an area under the curve of 0.77 [95% Cl: 0.74-0.80] to predict ESCC with 74% sensitivity and 70.4% specificity for the optimum cut point. The area under the curve was 0.71 [95% Cl: 0.64-0.79] for dysplasia diagnosis, and the classification table optimized at 61.5% sensitivity and 69.5% specificity. In this population, the positive and negative predictive values for diagnosis of dysplasia were 6.8% and 97.8%, respectively. Our models were able to discriminate between ESCC cases and controls in about 77%, and between individuals with and without squamous dysplasia in about 70% of the cases. Using risk factors to predict individual risk of ESCC or squamous dysplasia still has limited application in clinical practice, but such models may be suitable for selecting high risk individuals in research studies, or increasing the pretest probability for other screening strategies


Subject(s)
Humans , Carcinoma, Squamous Cell , Logistic Models , Risk
SELECTION OF CITATIONS
SEARCH DETAIL